Skip to main content
. 2023 May 10;56:23. doi: 10.1186/s40659-023-00437-2

Table 1.

General information of RDEB patients and healthy donors participating in this study

Sample Name Age Sex RDEB subtype Sample type Sample code Body location Mutations
SA01F 37 F - Skin biopsy NHF Abdomen -
SA02F 38 F - Skin biopsy NHF Abdomen -
SA03F 39 F - Skin biopsy NHF Abdomen -
SA04F 49 F - Skin biopsy NHF Abdomen -
SA05F 49 F - Skin biopsy NHF Abdomen -
Br1 N/A F - Skin biopsy NHF Breast -
Br2 N/A F - Skin biopsy NHF Breast -
RDEB1-01 month 3 3 F Gen. Int. Wound RDEB-CW Right heel c.6527insC/ c.6527insC
RDEB1-02 month 3 Left ankle
RDEB1-20 month 3 RDEB-AW Right elbow
pEB56F 19 M Gen. Int. Skin biopsy RDEB Right arm c.6527insC /c.-185 C > T
pEB111F 11 F Gen. Int. Skin biopsy RDEB Left arm

c.6527insC/

c.8329 C > T

pEB210F 18 F Gen. Severe Skin biopsy RDEB Ankle c.7708delG/ c.7708delG
RDEB4-03 month 0 20 M Gen. Severe Wound RDEB-AW Right leg c.6527insC/ c.6527insC
RDEB4-04 month 0 Right ankle

RDEB6-01 month 3

RDEB6-02 month 3

RDEB6-01 month 6

23 F Gen. Severe Wound RDEB-CW

Left arm

Left flank

Left arm

c.6527insC/ c.6527insC
pEB69F 25 Skin biopsy RDEB Ankle
RDEB8-01 month 0 24 F Gen. Severe Wound RDEB-CW Lumbar region c.6527insC/ c.7708delG